company background image

CignaNYSE:CI Stock Report

Market Cap







25 Oct, 2021


Company Financials +
CI fundamental analysis
Snowflake Score
Future Growth1/6
Past Performance4/6
Financial Health1/6

CI Overview

Cigna Corporation provides insurance and related products and services in the United States.

Cigna Competitors

CVS Health









Hims & Hers Health



Price History & Performance

Summary of all time highs, changes and price drops for Cigna
Historical stock prices
Current Share PriceUS$215.62
52 Week HighUS$160.37
52 Week LowUS$272.81
1 Month Change5.75%
3 Month Change-5.79%
1 Year Change18.55%
3 Year Change4.23%
5 Year Change81.45%
Change since IPO3,120.88%

Recent News & Updates

Oct 18
Here's Why I Think Cigna (NYSE:CI) Might Deserve Your Attention Today

Here's Why I Think Cigna (NYSE:CI) Might Deserve Your Attention Today

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Oct 14

Cigna: Now The Perfect Stock To Build A Retirement Portfolio Around

Cigna has seen material share price weakness in recent months, and trades in what I see as being deep-value territory. I see market concerns around the business as being overblown, and management targets robust free cash flow generation. The combination of potentially strong dividend growth and capital appreciation makes CI an ideal stock to own for a rich retirement.

Sep 23

Cigna: Getting Close To Being Very Attractive

It is an excellent business with a track record of consistent and stable growth. Free cash flow, operating earnings and stock chart performance are suggesting that business could be undervalued. High likelihood of double digits in investment returns.

Sep 18
At US$206, Is It Time To Put Cigna Corporation (NYSE:CI) On Your Watch List?

At US$206, Is It Time To Put Cigna Corporation (NYSE:CI) On Your Watch List?

Cigna Corporation ( NYSE:CI ) received a lot of attention from a substantial price movement on the NYSE over the last...

Sep 10

5 Reasons To Be Greedy With 'Super SWAN' Cigna

Cigna is a recent recommendation for those seeking long-term market and aristocrat-beating return potential. Cigna is a wonderful company with a great track record of achieving exceptional long-term returns. Cigna is considered a Super SWAN with 10% to 13% CAGR growth and perfect pick for any retiree.

Shareholder Returns

CIUS HealthcareUS Market

Return vs Industry: CI underperformed the US Healthcare industry which returned 27.4% over the past year.

Return vs Market: CI underperformed the US Market which returned 30.3% over the past year.

Price Volatility

Is CI's price volatile compared to industry and market?
CI volatility
CI Beta0.89
Industry Beta0.87
Market Beta1

Stable Share Price: CI is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: CI's weekly volatility (4%) has been stable over the past year.

About the Company

198172,963David Cordani

Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company’s U.S.

Cigna Fundamentals Summary

How do Cigna's earnings and revenue compare to its market cap?
CI fundamental statistics
Market CapUS$73.33b
Earnings (TTM)US$8.15b
Revenue (TTM)US$167.03b


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CI income statement (TTM)
Cost of RevenueUS$143.68b
Gross ProfitUS$23.34b

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

Nov 04, 2021

Earnings per share (EPS)23.97
Gross Margin13.98%
Net Profit Margin4.88%
Debt/Equity Ratio67.8%

How did CI perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio


Is Cigna undervalued compared to its fair value and its price relative to the market?


Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: CI ($215.62) is trading below our estimate of fair value ($556.3)

Significantly Below Fair Value: CI is trading below fair value by more than 20%.

Price To Earnings Ratio

PE vs Industry: CI is good value based on its PE Ratio (9x) compared to the US Healthcare industry average (20.9x).

PE vs Market: CI is good value based on its PE Ratio (9x) compared to the US market (18.2x).

Price to Earnings Growth Ratio

PEG Ratio: CI is poor value based on its PEG Ratio (1.8x)

Price to Book Ratio

PB vs Industry: CI is good value based on its PB Ratio (1.5x) compared to the US Healthcare industry average (3.2x).

Future Growth

How is Cigna forecast to perform in the next 1 to 3 years based on estimates from 16 analysts?


Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CI's forecast earnings growth (5.1% per year) is above the savings rate (2%).

Earnings vs Market: CI's earnings (5.1% per year) are forecast to grow slower than the US market (14.7% per year).

High Growth Earnings: CI's earnings are forecast to grow, but not significantly.

Revenue vs Market: CI's revenue (5.8% per year) is forecast to grow slower than the US market (9.9% per year).

High Growth Revenue: CI's revenue (5.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: CI's Return on Equity is forecast to be low in 3 years time (14.8%).

Past Performance

How has Cigna performed over the past 5 years?


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: CI has a large one-off gain of $3.7B impacting its June 30 2021 financial results.

Growing Profit Margin: CI's current net profit margins (4.9%) are higher than last year (3.4%).

Past Earnings Growth Analysis

Earnings Trend: CI's earnings have grown significantly by 32.9% per year over the past 5 years.

Accelerating Growth: CI's earnings growth over the past year (54.9%) exceeds its 5-year average (32.9% per year).

Earnings vs Industry: CI earnings growth over the past year (54.9%) exceeded the Healthcare industry 32.2%.

Return on Equity

High ROE: CI's Return on Equity (16.8%) is considered low.

Financial Health

How is Cigna's financial position?

Financial Position Analysis

Short Term Liabilities: CI's short term assets ($25.0B) do not cover its short term liabilities ($34.7B).

Long Term Liabilities: CI's short term assets ($25.0B) do not cover its long term liabilities ($70.7B).

Debt to Equity History and Analysis

Debt Level: CI's debt to equity ratio (67.8%) is considered high.

Reducing Debt: CI's debt to equity ratio has increased from 37.9% to 67.8% over the past 5 years.

Debt Coverage: CI's debt is not well covered by operating cash flow (18.1%).

Interest Coverage: CI's interest payments on its debt are well covered by EBIT (6.6x coverage).

Balance Sheet


What is Cigna current dividend yield, its reliability and sustainability?


Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: CI's dividend (1.86%) is higher than the bottom 25% of dividend payers in the US market (1.28%).

High Dividend: CI's dividend (1.86%) is low compared to the top 25% of dividend payers in the US market (3.48%).

Stability and Growth of Payments

Stable Dividend: CI's dividends per share have been stable in the past 10 years.

Growing Dividend: CI's dividend payments have increased over the past 10 years.

Current Payout to Shareholders

Dividend Coverage: With its low payout ratio (8.7%), CI's dividend payments are thoroughly covered by earnings.

Future Payout to Shareholders

Future Dividend Coverage: CI's dividends in 3 years are forecast to be well covered by earnings (18.1% payout ratio).

Next Steps


How experienced are the management team and are they aligned to shareholders interests?


Average management tenure


David Cordani (56 yo)





Mr. David Michael Cordani has been the Chief Executive Officer and President of Cigna Corporation since December 25, 2009 and June 2008 respectively and has been its Director since October 2009. Mr. Cordan...

CEO Compensation Analysis

Compensation vs Market: David's total compensation ($USD19.93M) is above average for companies of similar size in the US market ($USD11.15M).

Compensation vs Earnings: David's compensation has been consistent with company performance over the past year.

Leadership Team

Experienced Management: CI's management team is not considered experienced ( 2 years average tenure), which suggests a new team.

Board Members

Experienced Board: CI's board of directors are seasoned and experienced ( 10.3 years average tenure).


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: CI insiders have bought more shares than they have sold in the past 3 months.

Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Company Information

Cigna Corporation's employee growth, exchange listings and data sources

Key Information

  • Name: Cigna Corporation
  • Ticker: CI
  • Exchange: NYSE
  • Founded: 1981
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: US$73.334b
  • Shares outstanding: 340.11m
  • Website:

Number of Employees


  • Cigna Corporation
  • Wilde Building
  • 900 Cottage Grove Road
  • Bloomfield
  • Connecticut
  • 6002
  • United States


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/25 23:09
End of Day Share Price2021/10/25 00:00
Annual Earnings2020/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.